Capitalmind
Capitalmind
Actionable insights on equities, fixed-income, macros and personal finance Start 14-Days Free Trial
Actionable investing insights Get Free Trial

Archives

36 / 651

General

New Year Offer, Falling Lira, Ailing RBL, & More

In this week’s edition 1 TLDR post – where we quickly simplify the “too long” arduous stories that you “didn’t read” ...
b4-scaled.jpg
Premium Portfolio

3% Alpha on a No Downside Strategy for 2021 and the 2022 Gameplan

Over the past four years, we've been tracking and talking about this strategy called No-downside. In this post, we will bring together all that we've said, and ...
Nifty-No-downside-strategy-scaled.jpg
General

The Best of Capitalmind in 2021

Here's the best of Capitalmind in 2021: what worked and also what didn't work. Of a 10-bagger, an on-going 2-bagger, IPOs, Factor indices, Capitalmind Model ...
11-scaled.jpg
General

Ten minute delivery, Zero cost EMI, Dinosaur markets & More

In this week’s edition👇 1 TLDR summaries – where we quickly simplify the “too long” arduous stories that you “didn’t ...
b4-scaled.jpg
Personal Finance

How a Zero Cost EMI Actually Costs 9%

You've heard of the zero-cost EMI, no? You have to buy something, and instead of paying for it now, you just pay for it over 6 months. That's awesome, correct? ...
MaskEMI-scaled.jpg
General

Amazon pinched, Fed tapers, Investing Myths, Buying RBI Bonds & More

In this week’s edition 2 TLDR – where we quickly simplify the “too long” arduous stories that you “didn’t read” 3 ...
b4-scaled.jpg
Foundations

The five most commonly held Investing Myths

Investing is an interesting field. Not only because you make money out of it, and that money can do great things, from buying big shiny objects to letting you ...
myth-scaled.jpg
Charts & Analysis

Are Revenue and Earnings growth finally back?

We looked at the Revenue and Profit growth of over 1,700 public companies in India over the last 12 quarters to understand: how the pandemic hit their top ...
Is-growth-back-finally-scaled.jpg
Opinion

Why SEBI doesn’t want you getting advice from unregulated algos (EP43)

With technology comes great responsibility, says SEBI, as it attempts to regulate the algorithmic trading markets that have just started to evolve in India. ...
podcast-sebi-algo-trading.jpg
IPO

MedPlus IPO: Should you invest?

Six companies have raised money from the primary markets so far in December, while four more are opening this week – MedPlus, Data Patterns, Supriya ...
pharmacy-scaled.jpg